Literature DB >> 18652332

[Effects of electroacupuncture at different acupoint groups on behavior activity and p-CREB expression in hippocampus in the rat of depression].

Dong-mei Duan1, Ya Tu, Li-ping Chen.   

Abstract

OBJECTIVE: To observe therapeutic effects and mechanisms at different acupoint groups for treatment of the depression rat.
METHODS: Fifty Wistar rats were randomly divided into a normal group, a model group, a body acupoint group, a scalp acupoint group and a Fluoxetine hydrochloride group, 10 cases in each group. Depression rat model was established by using chronic unpredictable mild stress stimulation combined with lonely breeding for 21 days. EA (2 Hz, 1 mA, 20 min) was given at "Taichong" (LR 3), "Neiguan" (PC 6) and "Zusanli" (ST 36) in the body point group and "Baihui" (GV 20), "Yintang" (EX-HN 3), "Sishencong" (EX-HN 1) in the head point group, once daily, and Fluoxetine hydrochloride was given to the Fluoxetine hydrochloride group by intragastric administration, 2 mg/kg, once daily, for 21 days. Body weight of the rat was recorded, and the sucrose-intake test and forced swimming test were conducted one day before the experiment and on the 7th, 14th and 21st day of the experiment, and the open field test was conducted one day before the experiment and on the 21st day. p-CREB expression in the hippocampus of the rats were observed on the 22nd day.
RESULTS: As compared with the model group, in the head point group and the Fluoxetine group, the crossing and rearing movement times, the relative volume of sucrose-intake and p-CREB expression in the hippocampus increased significantly, and the duration of immovability in forced swimming test shortened significantly (P<0.05). The relative volume of sucrose-intake increased and the duration of immovability in forced swimming test in the body point group significantly shortened (P<0.05), but the crossing and rearing movement times and p-CREB expression in the hippocampus did not insignificantly increase (P>0.05), with no significant differences among the treatment groups (P>0.05).
CONCLUSION: EA at the head acupoints can improve behavioral activities and increase positive neuron number of p-CREB in the hippocampus of the depression rat, and selection of acupoints is of important role in treatment of depression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18652332

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  5 in total

1.  Effects of electroacupuncture at auricular concha region on the depressive status of unpredictable chronic mild stress rat models.

Authors:  Ru-Peng Liu; Ji-Liang Fang; Pei-Jing Rong; Yufeng Zhao; Hong Meng; Hui Ben; Liang Li; Zhan-Xia Huang; Xia Li; Ying-Ge Ma; Bing Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-29       Impact factor: 2.629

2.  Acupuncture Relieves the Excessive Excitation of Hypothalamic-Pituitary-Adrenal Cortex Axis Function and Correlates with the Regulatory Mechanism of GR, CRH, and ACTHR.

Authors:  Shao-Jun Wang; Jiao-Jiao Zhang; Li-Li Qie
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-11       Impact factor: 2.629

3.  Acupoint specificity on acupuncture regulation of hypothalamic- pituitary-adrenal cortex axis function.

Authors:  Shao-jun Wang; Jiao-jiao Zhang; Hao-yan Yang; Fang Wang; Si-ting Li
Journal:  BMC Complement Altern Med       Date:  2015-03-27       Impact factor: 3.659

4.  Proteomic response to acupuncture treatment in spontaneously hypertensive rats.

Authors:  Xinsheng Lai; Jiayou Wang; Neel R Nabar; Sanqiang Pan; Chunzhi Tang; Yong Huang; Mufeng Hao; Zhonghua Yang; Chunmei Ma; Jin Zhang; Helen Chew; Zhenquan He; Junjun Yang; Baogui Su; Jian Zhang; Jun Liang; Kevin B Sneed; Shu-Feng Zhou
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

5.  Acupuncture for behavioral changes of experimental depressive disorder: a systematic review and meta-analysis.

Authors:  Ren-Zhong Kou; Hong Chen; Mei-Ling Yu; Tian-Cheng Xu; Shu-Ping Fu; Sheng-Feng Lu
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.